Over the past decade, our group and others have highlighted the important role of aldosterone and its receptor, the mineralocorticoid receptor (MR) in obesity and in metabolic syndrome (MetS) [4,5,6,7], as well as in AT dysfunction [8]. This evidence concerns the gene NR3C2 and obesity disorder.